Cannabis in the News, Finance, Hemp, Investment Opportunities, marijuana stock
Why is MariMed Inc. a Great Penny Hemp Stock Investment Opportunity? Our review of MariMed Inc. has resulted in a strong buy rating for the company’s stock. Why is MariMed Inc. a Great Penny Hemp Stock Investment Opportunity? MariMed Inc. MRMD (OTC) is one of the...
Cannabis in the News, Finance, Financial Results, Health, Medical, Science, Hemp
Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update Piclidenoson has been submitted for the treatment of coronavirus under compassionate use program in Israel Top-line data from Phase II Namodenoson trial for NASH expected during April...
Cannabis in the News, Featured, Finance, International Cannabis News, Investment Opportunities
The Green Organic Dutchman Continues Cost Reduction Initiatives While Expanding Product Portfolio Centralizes cultivation operations at Ancaster Reduces workforce at Valleyfield Implements broad salary reduction for management and administration Sees strong interest...
Cannabis in the News, Cannabis Market, Finance, International Cannabis News, Investment Opportunities, Science
OTC Markets Group Welcomes Khiron Life Sciences Corp. to OTCQX NEW YORK, March 26, 2020 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Khiron Life Sciences Corp (TSX-V:...
Cannabis in the News, Finance, International Cannabis News, Investment Opportunities, Stock Talk
Emblem Corp. – Should You Invest in this Cannabis Stock? Our analysts encourage you to evaluate this little-known subsidiary of Aleafia Health because of their strong focus, outlook, and operations. Consider adding Emblem Corp to your marijuana stock portfolio....
Cannabis in the News, CBD in the News, Finance, Financial Results, Hemp, Research, Science
Therapix Biosciences Ltd. Announces Shareholder Conference Call TEL AVIV, Israel, March 25, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development...